BIOLASE (BIOL) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock BIOL vs. DYNT, NUWE, NAYA, SONX, IONM, HSDT, AFIB, BRSH, SDCCQ, and GMVDFShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Dynatronics (DYNT), Nuwellis (NUWE), NAYA Biosciences (NAYA), Sonendo (SONX), Assure (IONM), Helius Medical Technologies (HSDT), Acutus Medical (AFIB), Bruush Oral Care (BRSH), SmileDirectClub (SDCCQ), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. BIOLASE vs. Its Competitors Dynatronics Nuwellis NAYA Biosciences Sonendo Assure Helius Medical Technologies Acutus Medical Bruush Oral Care SmileDirectClub G Medical Innovations Dynatronics (NASDAQ:DYNT) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment. Which has more volatility and risk, DYNT or BIOL? Dynatronics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Which has better earnings and valuation, DYNT or BIOL? Dynatronics has higher earnings, but lower revenue than BIOLASE. Dynatronics is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDynatronics$33.60M0.04-$2.70M-$0.78-0.12BIOLASE$48.83M0.00-$20.63M-$14.94N/A Is DYNT or BIOL more profitable? Dynatronics has a net margin of -8.35% compared to BIOLASE's net margin of -41.65%. Dynatronics' return on equity of -41.81% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets Dynatronics-8.35% -41.81% -9.56% BIOLASE -41.65%-1,782.73%-55.31% Do analysts recommend DYNT or BIOL? BIOLASE has a consensus price target of $1.20, indicating a potential upside of 0.00%. Given BIOLASE's stronger consensus rating and higher possible upside, analysts clearly believe BIOLASE is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BIOLASE 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer DYNT or BIOL? In the previous week, Dynatronics' average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score. Company Overall Sentiment Dynatronics Neutral BIOLASE Neutral Do insiders & institutionals believe in DYNT or BIOL? 4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 8.8% of BIOLASE shares are owned by institutional investors. 8.0% of Dynatronics shares are owned by insiders. Comparatively, 0.3% of BIOLASE shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryBIOLASE beats Dynatronics on 7 of the 13 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$581K$493K$5.70B$9.51BDividend YieldN/AN/A4.69%4.01%P/E Ratio0.00N/A28.0720.05Price / SalesN/A0.01448.5799.42Price / CashN/AN/A36.2258.56Price / BookN/A0.018.665.87Net Income-$20.63M-$60.92M$3.25B$258.55M BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASE0.9673 of 5 starsN/A$1.20+∞-98.7%$581K$48.83M0.00160Gap DownDYNTDynatronicsN/A$0.09-7.4%N/A-63.7%$935K$33.60M-0.11200Gap DownNUWENuwellis3.034 of 5 stars$7.81+13.5%$714.00+9,042.1%-87.6%$812K$8.79M-0.0170High Trading VolumeNAYANAYA BiosciencesN/A$0.78-5.4%$24.00+2,993.6%N/A$517K$6.23M0.0010High Trading VolumeSONXSonendoN/A$1.15flatN/A+1,376.3%$493K$44.40M-0.02250IONMAssureN/A$0.03flatN/AN/A$91K$149K0.00130HSDTHelius Medical Technologies0.8754 of 5 stars$7.35-8.7%N/A-98.6%$74K$520K0.0030High Trading VolumeAFIBAcutus MedicalN/A$0.00+10.0%N/A-99.5%$66K$7.16M0.00340Gap UpBRSHBruush Oral CareN/AN/AN/AN/A$44K$2.92M0.0011Gap DownSDCCQSmileDirectClubN/AN/AN/AN/A$40K$470.74M0.002,700GMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072 Related Companies and Tools Related Companies Dynatronics Alternatives Nuwellis Alternatives NAYA Biosciences Alternatives Sonendo Alternatives Assure Alternatives Helius Medical Technologies Alternatives Acutus Medical Alternatives Bruush Oral Care Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
